SCHEMBL20112043

SCHEMBL20112043

N#Cc1cc(-n2c3ccccc3c3cc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)ccc32)c(-c2ccc(C(F)(F)F)cc2C(F)(F)F)c(-n2c3ccccc3c3cc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)ccc32)c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AR P10275 6/20 0.36
KIF11 P52732 3/20 0.35
ALOX5AP P20292 3/20 0.35
FEN1 P39748 2/20 0.35
CYP2C9 P11712 1/20 0.35
SCN9A Q15858 1/20 0.35
EDNRB P24530 1/20 0.34
EDNRA P25101 1/20 0.34
PGR P06401 2/20 0.32
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
TRPA1 O75762 1/20 0.31
PTGDR2 Q9Y5Y4 2/20 0.30
RXRA P19793 1/20 0.30
RXRG P48443 1/20 0.30
MAT2A P31153 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25659049 0.97 KIF11 (0.34) ARKIF11ALOX5APFEN1CYP2C9
SCHEMBL21258763 0.95 ALOX5AP (0.38) ARKIF11ALOX5APFEN1CYP2C9
SCHEMBL25659931 0.94 AR (0.38) ARKIF11ALOX5APFEN1CYP2C9
SCHEMBL21258780 0.94 KIF11 (0.34) ARKIF11ALOX5APFEN1CYP2C9
SCHEMBL21258604 0.94 KIF11 (0.35) ARKIF11ALOX5APFEN1CYP2C9
SCHEMBL21414194 0.94 AR (0.35) ARKIF11ALOX5APFEN1CYP2C9
SCHEMBL20111873 0.94 KIF11 (0.40) ARKIF11ALDH1A1MAPTSMN1; SMN2
SCHEMBL20112037 0.94 KIF11 (0.38) ARKIF11ALOX5APFEN1CYP2C9
SCHEMBL21258727 0.94 KIF11 (0.38) ARKIF11CYP2C9SCN9AMAT2A
SCHEMBL20111871 0.93 AR (0.38) ARKIF11ALOX5APFEN1EDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10971688-B2 Organic molecules for use in organic optoelectronic devices CYNORA GMBH (DE) 2021-04-06 US disclosed
US-20190248741-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-15 US disclosed
EP-3360945-B1 ORGANIC ELECTROLUMINESCENT DEVICE CYNORA GMBH (DE) 2019-04-24 EP disclosed
WO-2018077492-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10971688-B2 Organic molecules for use in organic optoelectronic devices OR10J3, OR51E2, OPRM1 AR 4611/4885KIF11 3426/4885ALOX5AP 2592/4885
US-20190248741-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 AR 4386/4885KIF11 3661/4885ALOX5AP 3253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.